Article info
PDFPolitical philosophy and medical ethics
Paper
Cognitive neuroenhancement: false assumptions in the ethical debate
- Correspondence to Dr Roland Kipke, University of Tübingen, International Centre for Ethics in the Sciences and Humanities (IZEW), Wilhelmstrasse 19, Tübingen 72074, Germany; kipke{at}izew.uni-tuebingen.de
Citation
Cognitive neuroenhancement: false assumptions in the ethical debate
Publication history
- Received June 9, 2011
- Revised December 6, 2011
- Accepted December 8, 2011
- First published January 6, 2012.
Online issue publication
April 27, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Other content recommended for you
- Neuroenhancers, addiction and research ethics
- Neuropsychiatry of the basal ganglia
- True and false concerns about neuroenhancement: a response to ‘Neuroenhancers, addiction and research ethics’, by D M Shaw
- Parkinson disease and impulse control disorders: a review of clinical features, pathophysiology and management
- Sugar addiction: is it real? A narrative review
- Extrastriatal dopaminergic changes in Parkinson’s disease patients with impulse control disorders
- Psychostimulant effect of levodopa: reversing sensitisation is possible
- The use of methylphenidate among students: the future of enhancement?
- A selective literature review exploring the role of the nicotinic system in schizophrenia
- Smart drugs for cognitive enhancement: ethical and pragmatic considerations in the era of cosmetic neurology